Nearly 20% of patients with TNBC harbor a breast cancer susceptibility gene (BRCA) mutation, particularly BRCA1, compared to 6% of all breast cancers associated with a BRCA mutation [2]. The gene discussed is BRCA1; the disease is breast cancer.